jain.com

CEO Special RSU Grant

Company: Core Scientific

This claim was marked delayed on September 4, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
personnel
Statement date
2024-06-16
Promised by
2025-01-23
Promised amount
2867521.0 units
Current status
delayed

The claim, verbatim

Special one-time grant of 2,867,521 time-based RSUs vesting in four equal amounts beginning January 23, 2025

Source (primary)

Core Scientific 8-K filed 2024-06-17 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗

Quote: “A special one-time grant of 2,867,521 time-based restricted stock units under the Equity Plan ("RSUs"), which will vest in four equal amounts, with one-fourth vesting on January 23, 2025 and one-fourth vesting on each of the next three anniversaries of such initial vesting date”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms Core Scientific 8-K filed 2024-06-17

Quote: “A special one-time grant of 2,867,521 time-based restricted stock units under the Equity Plan ("RSUs"), which will vest in four equal amounts, with one-fourth vesting on January 23, 2025 and one-fourth vesting on each of the next three anniversaries of such initial vesting date”

View cached copy (2026-08-31)Live source ↗

Record of changes

September 3, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 4, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.